Literature DB >> 28197887

The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Mikael Koskela1, Elisa Ylinen2, Elli-Maija Ukonmaanaho3, Helena Autio-Harmainen4, Päivi Heikkilä5, Jouko Lohi5, Outi Jauhola6, Jaana Ronkainen7, Timo Jahnukainen2, Matti Nuutinen3,8.   

Abstract

BACKGROUND: Histological findings from primary kidney biopsies were correlated with patient outcomes in a national cohort of paediatric Henoch-Schönlein nephritis (HSN) patients.
METHODS: Primary kidney biopsies from 53 HSN patients were re-evaluated using the ISKDC (International Study of Kidney Disease in Children) classification and a modified semiquantitative classification (SQC) that scores renal findings and also takes into account activity, chronicity and tubulointerstitial indices. The ISKDC and SQC classifications were evaluated comparatively in four outcome groups: no signs of renal disease (outcome A, n = 27), minor urinary abnormalities (outcome B, n = 18), active renal disease (outcome C, n = 3) and renal insufficiency, end-stage renal disease or succumbed due to HSN (outcome D, n = 5). For the receiver operating characteristic and logistic regression analyses, outcomes A and B were considered to be favourable and outcomes C and D to be unfavourable. The median follow-up time was 7.3 years.
RESULTS: The patients with an unfavourable outcome (C and D), considered together due to low patient numbers, had significantly higher total biopsy SQC scores and activity indices than those who had a favourable one (groups A and B). The chronicity and tubulointerstitial indices differed significantly only between group C + D and group A. The difference in areas under the curve between the total biopsy SQC scores and ISKDC findings was 0.15 [p = 0.04, normal-based 95% confidence interval (CI) 0.007-0.29, bias-controlled 95% CI -0.004 to 0.28].
CONCLUSIONS: Our results suggest that the modified SQC is more sensitive than ISKDC classification for predicting the outcome in HSN cases.

Entities:  

Keywords:  Children; Glomerulonephritis; Histology; Renal biopsy; Semiquantitative; Vasculitis

Mesh:

Year:  2017        PMID: 28197887     DOI: 10.1007/s00467-017-3608-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  33 in total

1.  Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

2.  Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

Authors:  Rosanna Coppo; Simeone Andrulli; Alessandro Amore; Bruno Gianoglio; Giovanni Conti; Licia Peruzzi; Francesco Locatelli; Leonardo Cagnoli
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

Review 3.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

Authors:  J C Davin; I J Ten Berge; J J Weening
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

4.  Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.

Authors:  Outi Jauhola; Jaana Ronkainen; Helena Autio-Harmainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2011-05-28       Impact factor: 3.714

5.  Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes.

Authors:  Hitoshi Wakaki; Kenji Ishikura; Hiroshi Hataya; Yuko Hamasaki; Tomoyuki Sakai; Nahoko Yata; Tetsuji Kaneko; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-03-04       Impact factor: 3.714

6.  Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Arch Dis Child       Date:  2010-09-18       Impact factor: 3.791

7.  Estimation and Comparison of Receiver Operating Characteristic Curves.

Authors:  Margaret Pepe; Gary Longton; Holly Janes
Journal:  Stata J       Date:  2009-03-01       Impact factor: 2.637

8.  The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study.

Authors:  Jaana Ronkainen; Matti Nuutinen; Olli Koskimies
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

9.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  14 in total

1.  Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.

Authors:  Camille Dumont; Aicha Mérouani; Thierry Ducruet; Geneviève Benoit; Marie-Josée Clermont; Anne Laure Lapeyraque; Véronique Phan; Natalie Patey
Journal:  Pediatr Nephrol       Date:  2020-01-13       Impact factor: 3.714

Review 2.  IgA vasculitis nephritis in children and adults: one or different entities?

Authors:  Licia Peruzzi; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

Review 3.  IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Authors:  M Colleen Hastings; Dana V Rizk; Krzysztof Kiryluk; Raoul Nelson; Rima S Zahr; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2021-04-05       Impact factor: 3.651

4.  Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis.

Authors:  Xiaohan Huang; Lili Ma; Pingping Ren; Hongya Wang; Liangliang Chen; Haidongqin Han; Jianghua Chen; Fei Han
Journal:  Diagn Pathol       Date:  2019-05-10       Impact factor: 2.644

5.  Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis.

Authors:  Dongmei Shi; Han Chan; Xia Yang; Gaofu Zhang; Haiping Yang; Mo Wang; Qiu Li
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

Review 6.  Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?

Authors:  Marija Jelusic; Mario Sestan; Rolando Cimaz; Seza Ozen
Journal:  Pediatr Rheumatol Online J       Date:  2019-02-28       Impact factor: 3.054

7.  Epidemiology of 10-year paediatric renal biopsies in the region of southern Croatia.

Authors:  Adela Arapović; Katarina Vukojević; Natalija Filipović; Merica Glavina Durdov; Danica Ljubanović-Galešić; Mirna Saraga-Babić; Sandra Prgomet; Ana Simičić Majce; Anja Belavić; Dijana Borić Škaro; Dragan Ljutić; Marijan Saraga
Journal:  BMC Nephrol       Date:  2020-02-26       Impact factor: 2.388

8.  Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.

Authors:  Ying Zhu; Yang Dong; Lin Wu; Fang Deng
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

9.  Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.

Authors:  Yong-Rui Song; Wan-Liang Guo; Mao Sheng; Qiang Lin; Xue-Ming Zhu; Xiao-Zhong Li
Journal:  BMC Pediatr       Date:  2020-11-02       Impact factor: 2.125

10.  Less IgA deposits with more severe disease: the immunoclinical paradox in Henoch-Schönlein Purpura with MEFV mutations.

Authors:  Ufuk İlgen; Gökhan Nergizoğlu
Journal:  Clin Rheumatol       Date:  2019-07-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.